2 FDA committee members resign over Biogen Alzheimer's drug approval
Fallout over the FDA’s recent decision to grant Biogen’s Alzheimer’s drug accelerated approval has seen two advisory panel members resign.
Full Article
2 FDA committee members resign over Biogen Alzheimer's drug approval
Upworthy
0 shares
1 views
You might like
Related news coverage
Why Biogen's FDA Approval Is Shocking
Motley Fool
Many doctors don't like the drug, and the trial data was underwhelming. Nonetheless, Biogen's Alzheimer's drug was approved-- and..
-
Two House committees to investigate FDA's approval of Biogen's Alzheimer's drug
SeekingAlpha
-
Lilly to seek FDA approval for potential Alzheimer's drug
SeattlePI.com
-
How the new Alzheimer’s disease drug could influence future research
Upworthy
-
Another Biogen Alzheimer's drug expedited by the FDA
bizjournals
Advertisement
More coverage
Top stock stories from Wednesday: Microsoft hits milestone valuation, Amazon details green strategy, Shake Shack expands in China
Invezz
U.S. FDA struggles with Biogen’s Alzheimer drug’s approval The U.S. Food and Drug Administration (FDA) met with disagreements..
-
FDA documents show struggle over approval of new Alzheimer’s drug from Biogen
Indian Express
-
FDA officials should resign over 'reckless' approval of Biogen Alzheimer’s drug, says US consumer rights group
Proactive Investors
-
First patient set to receive controversial Biogen Alzheimer' s drug
MENAFN.com
-
The F.D.A.'s Approval of Biogen's Alzheimer's Drug Is a New Low
NYTimes.com